INTRODUCTION
Radiochemotherapy is effective in clinical applications against many types of cancer. In this therapy, an improvement of the therapeutic index depends on selecting the drug which causes radiation damage to the tumor and/or radioprotection for normal cells 1, 2) . Therefore, the development of radiosensitizers or radioprotectors, which change the radiosensitivity of cells, is important in radiochemotherapy.
The screening of radiosensitizers and radioprotectors is essential for the improvement of radiochemotherapy. The systems for measuring radioprotective activity are classified into 2 categories: cell-level experiments and whole body-level experiments. Although the cell-level experiments are convenient, there are many problems in extrapolating the results into wholebody experiments. On the other hand, whole body-level experiments, in which the radioprotective and/or radiosensitive effects of various compounds are measured by the 30-day survival of mice (LD 50/30 ) against high-dose radiation, require many mice as well as killing the animals; it is also time-consuming to obtain the data. Therefore, a more convenient in vivo method which uses fewer mice and yields results more quickly is preferable for the second step of the screening of various compounds following the first step of cell-level screening.
We have previously reported that the decay rate of carbamoyl-PROXYL (3-carbamoyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl), a nitroxyl radical, in whole mice measured by in vivo ESR was increased by X-irradiation 3) , and that this increase was suppressed adequately by the pre-administration of a radioprotector, cysteamine. This finding has suggested that the signal decay of nitroxyl obtained by in vivo ESR might be applicable to measuring radiation damage in organisms. Thus, in the present study, in order to study the possibility of applying in vivo ESR to in vivo screening of radioprotectors, we examined the suppression effect of various radioprotectors on an X-ray-induced enhancement of nitroxyl decay.
MATERIALS AND METHODS

Chemicals
3-Carbamoyl-2,2,5,5-tetramethyl-pyrrolidine-N-oxyl (carbamoyl-PROXYL), 2-carboxy-2,5,7,8-tetramethyl-6-chromanol (Trolox) and 4-hydroxy-2,2,6,6-tetramethyl-piperidine-Noxyl (TEMPOL) were purchased from Aldrich Chemical Co. Inc. (Milwaukee, WI). Pentobarbital (50 mg/ml) was obtained from Dainabot Co., Ltd. (Osaka, Japan). Interleukin-1β (IL-1β, mouse, recombinant), stem cell factor (SCF, mouse, recombinant), 5-hydroxytryptamine (5-HT) and cimetidine were purchased from Sigma Chemical Co. (St. Louis, MO). L-Ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6yl hydrogen phosphate] potassium salt (EPC-K 1 ) and S-2-(3-aminopropylamino)-ethylphosphorothioic acid (WR-2721) were gifts from Senju Pharmaceutical Co. (Osaka, Japan) and Dr. K. Ando, National Institute of Radiological Sciences, respectively. All other reagents were of the highest grade commercially available.
Animals
Female ddY mice (3 weeks, 10-15 g body weight) were purchased from Japan SLC, Inc. (Hamamatsu, Japan).
X-irradiation
The X-irradiation of mice (200 kV, 20 mA) was performed as described in our previous report 3) . Several mice were placed in individual chambers and simultaneously given a single whole-body exposure to X-rays. Sham irradiation included comparable immobilization in the same irradiation chamber. The irradiation was performed without anesthetization of the mice.
Administration of radioprotectors
The dose and timing of the administration of radioprotectors are very important for studying radioprotection. We determined the conditions of the radioprotector treatment based on our references, which reported a reduction of radiation lethality in mice (Table 1) 4-8) . The doses of antioxidants, Trolox and EPC-K 1 , were determined according to a report 9) in which some in vivo effects were observed. 5-HT, WR-2721, cimetidine, TEMPOL, EPC-K 1 , IL-1β and SCF were dissolved in sterilized saline. Trolox was dissolved in sterilized saline containing 2% ethanol. As control groups, mice were administered sterilized saline (0.2 ml, i.p.) 20 min (control A) or 20 h (control B) before irradiation, or 2% ethanol in sterilized saline (0.2 ml, i.p.) 20 min before irradiation (control C).
In vivo ESR measurement
An in vivo ESR apparatus (JES-PE, JEOL, Tokyo, Japan) was equipped with an L-band microwave power unit (ES-LB1A, JEOL) and a loop-gap resonator. As described in our previous report 3) , each anesthetized mouse was fixed on a Teflon holder and placed in the resonator of an in vivo ESR apparatus. A sterilized solution of carbamoyl-PROXYL (280 mM) was injected into the tail vein of the mouse (50 µl). Immediately after injection, an ESR spectrum was measured in the upper abdomen; measurements were repeated for about 10 min at regular time intervals (Fig. 1a) . The rate of nitroxyl decay was calculated from the slope of the signal decay curve (Fig. 1b ) within 10 min after injection using a semilogarithmic plot of the peak height of the first line of the 3-line ESR signal.
Effects of radiation on the rates of nitroxyl decay
The mice were separated into 2 groups. Both group A and B were administered with a radioprotector or an antioxidant at the same dose and timing, as summarized in Table 1 . Group A was sham irradiated, and group B was irradiated by X-rays at a dose of 15 Gy (ca. 0.6 Gy/min). One hour after the X-irradiation or the sham-irradiation, the mice were anesthetized, and carbamoyl-PROXYL was injected into tail vein. The ESR spectra of the nitroxyl radical were repeatedly measured in the upper abdomen of the mice. From the signal decay curves of each mouse, the rate constants of nitroxyl decay were calculated. The rate constant of the signal decay for each mouse in X-irradiated group B was divided by the average of that of group A (sham-irradiated group) measured during the same day. This ratio was defined as the signal decay increase factor (IF): IF = Decay rate constant (X-irradiation) / Decay rate constant (sham-irradiation). The significance of the difference in IF between control and radioprotector-treated mice was calculated by Students' t-test; all P values are 2-sided.
Estimation of Radioprotection
The suppression index (SI) against the signal decay increase factor (IF) was defined as
where IF control and IF radioprotector represent the signal decay increase factors of controls and radioprotector-treated mice, respectively. The SI values should normally range between 0 and 100.
If the compound has a higher suppression activity, the SI value becomes larger.
RESULTS
ESR spectrum and increase of signal decay rate due to X-irradiation
An ESR spectrum with 3 sharp lines of carbamoyl-PROXYL was observed in the upper abdomens of mice (Fig. 1a) , and the signal intensities decayed with time after the injection of nitroxyl. From the slope of the signal decay curve (Fig. 1b) , the rate constant of nitroxyl decay was calculated. The rate constants of nitroxyl decay of 15 Gy-irradiated mice measured at 1 h after the irradiation were larger than that of sham-irradiated mice, as described previously 3) . The signal decay increase factor (IF) was calculated to be 1.167 ± 0.021 for control A (Fig. 2) . Control C showed a similar IF value (1.165 ± 0.050), while control B showed a slightly 5 min before irradiation 4) 0.975 115 40 mg/kg, i.p. 4) 5 min before irradiation 4) 1.146 13 WR-2721 200 mg/kg, i.p. 4) 30 min before irradiation 4) 0.98 112 400 mg/kg, i.p. 4) 30 min before irradiation 4) 1.118 29 Cimetidine 15 mg/kg, i.p. 19 h before irradiation 7) 1.008 92 SCF 62.5 µg/kg, s.c. The pre-administration of conventionally used radioprotectors suppressed the IF values, as shown in Fig. 2 Antioxidants also showed high SI values. The SI values of EPC-K 1 were shown to increase from 46 (1 mg/kg) to 100 (10 mg/kg) dose-dependently. Trolox was very efficient in both low and high doses with SIs of 118 (0.1 mg/kg) and 111 (1 mg/kg). Trolox suppressed the enhancement of nitroxyl decay due to hyperoxia 10) .
DISCUSSION
Many compounds have been reported to be radioprotectors, including thiols, radical scavengers, cytokines, superoxide dismutase, vasoconstrictors, and sodium tungstate 11) . Various radioprotectors have various mechanisms for their radioprotection activity: e.g., radical scavenging, the induction of antioxidative enzymes, the induction of hypoxia in tissue, the induction of a radioresistant state in the cell cycle, hydrogen donation to target radicals, and stimulation of the immunosystems 12, 13) . 5-HT, a vasoconstrictor and a central nervous system (CNS)-regulator, was reported to be radioprotective due to the induction of hypoxia and the stimulation of some regulatory functions of the CNS 4, 14) . WR-2721, one of the most remarkable anticancer drugs 15, 16) , is dephosphorylized to active free thiol by alkaline phosphatase in cells, and becomes a powerful radioprotector 17, 18) . Cimetidine, an antagonist of histamine type II receptors that is used clinically for treating peptic ulcers, is reported to be radioprotective due to its radical scavenging ability 19, 20) and stimulation of the immunosystem 5) . TEMPOL, which is reportedly a SOD mimic, a radical scavenger and an antioxidant 21) , showed powerful radioprotection ability 6, 22) . Inflammatory cytokines, such as IL-1β, are known to release by irradiation 23) , while IL-1β and SCF were also reported to be radioprotective by various mechanisms, including stimulation of the immunosystem, the regulation of cell cycling, and induction of the antioxidative enzymes 7, 24, 25) . Up to now, radioprotective activity had been assayed based on the 30-day survival of mice. The dose reduction factor (DRF) was widely used as an index of the radioprotective activity. If a compound is radioprotective, the value of DRF of the compound becomes larger than 1.0. The DRFs of the above-mentioned radioprotectors were reported to be 1.2-2.6 [4] [5] [6] [7] [8] .
In the present study using in vivo ESR, all of the radioprotectors examined showed positive SI values in spite of their variety of radioprotection mechanisms. Because the mice used in the DRF and SI experiments were not identical in strain, weight or age, the conditions necessary for a treatment with radioprotectors to obtain the maximum SI value may be different from those required to obtain the maximum DRF value. Nevertheless, there seems to be a positive correlation between SI and DRF, the value defined in the in vivo ESR method and that conventionally used as the radioprotective index, respectively. Therefore, this in vivo ESR method may be applicable for the second step of screening in vivo, for radioprotecting the activity of various compounds.
Although carbamoyl-PROXYL, which we used as a spin probe for an in vivo ESR measurement, is also reported to be radioprotective 26) , the radioprotective effect of nitroxyl radical was observed only when it was administered prior to irradiation. Therefore, because we injected carbamoyl-PROXYL into mice 1 h after irradiation, the radioprotective effect of carbamoyl-PROXYL can be regarded as being negligible in the present measurements.
The IF values of the 3 different controls were a slightly scattered. We cannot explain at present why the timing of the administration of saline affected the IF values. The control IF values obtained in the present study were slightly smaller than that mentioned in our previous report 3) . A probable reason for this decrease in the IF values in the control experiments is that the length of the loop-gap resonator of the in vivo ESR apparatus was changed from 30 mm in the previous study to 5 mm in the present study, which would have changed the signal-detection area of the mice.
We did not observe any dose-dependent change in the SI values for WR-2721 and 5-HT, since even larger SI values were observed at smaller doses for these compounds in restricted experiments. Although it is not clear why this adverse dose-dependency was observed for WR-2721 and 5-HT, we should keep in mind that the survival of mice represents a systemic effect, whereas in vivo ESR observes the local effect in the upper abdomen. In addition, a high dose of WR-2721 and 5-HT might cause other effects on the redox reaction of nitroxyl in the whole body.
In the present study, Trolox and EPC-K 1 showed high SI values. Although Trolox and EPC-K 1 have not been recognized as radioprotectors, they were reported to suppress various oxidative stresses in vivo 9, 27, 28) . Since the enhancement of the decay rate of nitroxyl due to irradiation seems to be attributable to the formation of ROS in organisms due to irradiation 3) , the antioxidants Trolox and EPC-K 1 may have well suppressed the enhancement by scavenging ROS in tissues. Since Trolox and EPC-K 1 showed high SI values in the present study, we have tried to examine their radioprotective activity using the mouse survival method. However, we did not observe any radioprotective activity (data not shown). These results indicate that not all of the compounds showing high SI values are necessarily radioprotective with respect to mouse survival.
Unfortunately, this in vivo ESR system cannot be used in place of the 30-day survival method using many mice. However, this system is non-invasive and more convenient than the mouse survival test. Consequently, the in vivo ESR system probing nitroxyl radical can be a novel candidate as a convenient in vivo, non-invasive screening system for radioprotective activity.
